Main Article Content

Maria Pina Dore
Giovanni Mario Pes
Sandro Mereu
Jessica Piroddu
Lorenzo Cavagna
Gian Luca Erre


Glucose-6-phosphate dehydrogenase deficiency, autoimmunity, oxidative stress, inflammation, connective tissue-diseases


Carriers of G6PD deficiency were at an increased risk of RA. This finding opens new windows to better understanding the RA pathogenesis.


Download data is not yet available.

Abstract 189
PDF Downloads 99
HTML Downloads 23


1. Goss SJ, Harris H. Gene transfer by means of cell fusion I. Statistical mapping of the human X-chromosome by analysis of radiation-induced gene segregation. J Cell Sci. Jun 1977;25:17-37. doi:10.1242/jcs.25.1.17
2. Weiss SJ. The role of superoxide in the destruction of erythrocyte targets by human neutrophils. J Biol Chem. Oct 25 1980;255(20):9912-7.
3. Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. Sep 10 2020;136(11):1225-1240. doi:10.1182/blood.2019000944
4. Parsanathan R, Jain SK. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is linked with cardiovascular disease. Hypertens Res. Jun 2020;43(6):582-584. doi:10.1038/s41440-020-0402-8
5. Bocchetta A. Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects. Ann Gen Hosp Psychiatry. Jun 13 2003;2(1):6. doi:10.1186/1475-2832-2-6
6. Israel A, Schäffer AA, Berkovitch M, et al. Glucose-6-phosphate dehydrogenase deficiency and long-term risk of immune-related disorders. Original Research. Frontiers in Immunology. 2023-September-11 2023;14doi:10.3389/fimmu.2023.1232560
7. Dore MP, Fanciulli G, Pes GM. Is Glucose-6-Phosphate Dehydrogenase Deficiency a Risk Factor for Autoimmune Thyroid Disease? A Retrospective Case-Control Study. Int J Environ Res Public Health. Feb 3 2023;20(3)doi:10.3390/ijerph20032709
8. Erre GL, Mameli G, Cossu D, et al. Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis. Viral Immunol. Sep 2015;28(7):385-90. doi:10.1089/vim.2015.0035
9. Mangoni AA, Tommasi S, Sotgia S, et al. Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis? Curr Pharm Des. 2021;27(18):2131-2140. doi:10.2174/1381612827666210106144247
10. Bo M, Erre GL, Bach H, et al. PtpA and PknG Proteins Secreted by Mycobacterium avium subsp. paratuberculosis are Recognized by Sera from Patients with Rheumatoid Arthritis: A Case-Control Study. J Inflamm Res. 2019;12:301-308. doi:10.2147/JIR.S220960
11. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. Apr 23 2018;361:k1036. doi:10.1136/bmj.k1036
12. Gardi C, Bauerova K, Stringa B, et al. Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Arch Biochem Biophys. Oct 1 2015;583:150-7. doi:10.1016/
13. Wruck CJ, Fragoulis A, Gurzynski A, et al. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis. May 2011;70(5):844-50. doi:10.1136/ard.2010.132720
14. Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol. Jan-Feb 2001;21(1):69-73. doi:10.1002/jat.736
15. Fiorelli G, Meloni T, Palomba V, Manoussakis C, Villa S, Cappellini MD. Gene frequency of glucose-6-phosphate dehydrogenase (G6PD) polymorphic variants in Sardinia. Gene Geogr. Dec 1990;4(3):139-42.
16. De Vita G, Alcalay M, Sampietro M, Cappelini MD, Fiorelli G, Toniolo D. Two point mutations are responsible for G6PD polymorphism in Sardinia. Am J Hum Genet. Feb 1989;44(2):233-40.
17. Sardu C, Cocco E, Mereu A, et al. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One. 2012;7(3):e32487. doi:10.1371/journal.pone.0032487
18. Rossini M, Rossi E, Bernardi D, et al. Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int. May 2014;34(5):659-64. doi:10.1007/s00296-014-2974-6
19. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. Sep 2010;62(9):2569-81. doi:10.1002/art.27584
20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. Mar 1988;31(3):315-24. doi:10.1002/art.1780310302
21. Bampton JL, Cawston TE, Kyle MV, Hazleman BL. Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis. Jan 1985;44(1):13-9. doi:10.1136/ard.44.1.13
22. Mosca A, Paleari R, Rosti E, et al. Simultaneous automated determination of glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in whole blood. Eur J Clin Chem Clin Biochem. May 1996;34(5):431-8. doi:10.1515/cclm.1996.34.5.431
23. Pes GM, Errigo A, Bitti A, Dore MP. Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults. Ann Med. Feb 2018;50(1):68-73. doi:10.1080/07853890.2017.1390247
24. Li P, Stuart EA, Allison DB. Multiple Imputation: A Flexible Tool for Handling Missing Data. JAMA. Nov 10 2015;314(18):1966-7. doi:10.1001/jama.2015.15281
25. Dore MP, Portoghese M, Pes GM. The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease. J Atheroscler Thromb. Jun 1 2021;28(6):604-610. doi:10.5551/jat.56531
26. Gheita TA, Kenawy SA, El Sisi RW, Gheita HA, Khalil H. Subclinical reduced G6PD activity in rheumatoid arthritis and Sjogren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome. Mod Rheumatol. Jul 2014;24(4):612-7. doi:10.3109/14397595.2013.851639
27. Errigo A, Bitti A, Galistu F, Salis R, Pes GM, Dore MP. Relationship between Glucose-6-Phosphate Dehydrogenase Deficiency, X-Chromosome Inactivation and Inflammatory Markers. Antioxidants (Basel). Jan 31 2023;12(2)doi:10.3390/antiox12020334
28. Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. Jun 2008;152(3):415-22. doi:10.1111/j.1365-2249.2008.03634.x
29. Quinonez-Flores CM, Gonzalez-Chavez SA, Del Rio Najera D, Pacheco-Tena C. Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review. Biomed Res Int. 2016;2016:6097417. doi:10.1155/2016/6097417
30. Wang X, Fan D, Cao X, et al. The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment. Antioxidants (Basel). Jun 13 2022;11(6)doi:10.3390/antiox11061153
31. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med. Mar 2003;45(1):7-13.
32. TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. Aug 2023;5(8):1275-1289. doi:10.1038/s42255-023-00863-2
33. Kalpakcioglu B, Senel K. The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. Feb 2008;27(2):141-5. doi:10.1007/s10067-007-0746-3
34. Sanna F, Bonatesta RR, Frongia B, et al. Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects. J Vasc Res. 2007;44(4):253-63. doi:10.1159/000100903
35. Bira Y, Tani K, Nishioka Y, et al. Transforming growth factor beta stimulates rheumatoid synovial fibroblasts via the type II receptor. Mod Rheumatol. 2005;15(2):108-13. doi:10.1007/s10165-004-0378-2
36. Dore MP, Vidili G, Marras G, Assy S, Pes GM. Inverse Association between Glucose‒6‒Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma. Asian Pac J Cancer Prev. Apr 27 2018;19(4):1069-1073. doi:10.22034/APJCP.2018.19.4.1069